FDA: Eczema Drugs Carry Cancer Risk

WASHINGTON (Reuters) - Two eczema creams -- Novartis AG's Protopic, must carry a strong warning of cancer risk, the U.S. Food and Drug Administration said on Thursday.

Continue to FDA: Eczema Drugs Carry Cancer Risk on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz